Director Medical Affairs at Philip Morris International, is responsible to define and implement Scientific and Medical Affairs strategies related to RRPs and to provide scientific and medical leadership with regards to the RRP communication strategy, scientfic and medical education on RRPs as well as leading the product messaging strategy for PMI RRPs from a medical perspective. He previously led the clinical development program for PMI RRPs and the efforts to develop and implement a disease risk reduction program to substantiate and quantify RRP risk in a post-market setting. Patrick is a Medical Doctor and his experience ranges from practicing medicine in an emergency room setting to working for various industries with in depth experience in Clinical Research and Development and Scientific and Medical Affairs.
Share articles :